Akebia Therapeutics (AKBA) Operating Margin (2016 - 2026)
Akebia Therapeutics (AKBA) operating margin from Dec 31, 2016 to Mar 31, 2026. The current Akebia Therapeutics (AKBA) operating margin is -8.78%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Akebia Therapeutics (AKBA)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 9.95% | -131.58% |
| 2024 | -31.51% | +32.56% |
| 2023 | -23.77% | -13.94% |
| 2022 | -27.62% | N/A |
| 2022 | -27.62% | -77.77% |
| 2021 | -124.23% | -0.60% |
| 2021 | -124.97% | +332.14% |
| 2020 | -28.92% | -77.45% |
| 2020 | -128.23% | +50.05% |
| 2019 | -85.46% | -0.35% |
| 2018 | -85.76% | +102.72% |
| 2017 | -42.31% | -99.52% |
| 2016 | -8861.04% | N/A |
Comparison Akebia Therapeutics (AKBA) operating margin with competitors
Akebia Therapeutics (AKBA) operating margin is -8.78%.